Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 6Recruiting 3Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 36NETWORK 5NIH 4OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms, Squamous Cell 1Esophageal Neoplasms 1

Interventions

Gemcitabine 4Cisplatin 4Rituximab 2Fluorouracil 2Everolimus 2tislelizumab 1phosphorylethanolamine 1parsaclisib 1human papillomavirus vaccine, L1 type 16, 18 1famitinib 1dalpiciclib 1Zinc Sulfate 1Zinc 1Vitamin B 6 1Tamoxifen 1Sunitinib 1Sorafenib 1Radiotherapy, Adjuvant 1Pyridoxine 1Proton Pump Inhibitors 1Prednisone 1Platelet Transfusion 1Photochemotherapy 1Pemetrexed 1Patient Portals 1Paclitaxel 1Oxaliplatin 1Neoadjuvant Therapy 1N-hydroxy-4-acetylaminostilbene 1N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × OTHER_GOV × Neoadjuvant Therapy × Clear all
NCT00559351 2007-11-16

RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus

Ministry of Scientific Research and Information Technology, Poland

Phase 3 Terminated
84 enrolled
Gastrointestinal

Esophageal Neoplasms, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡